Benchmark suite

Labile Cell Benchmark

A paid benchmark suite for predicting treatment-induced gene-expression responses in human hair follicles, spanning four experimental studies.

Request benchmark

All benchmarksPaid benchmark suite

Benchmark access by request

Review the included datasets below, then request the suite to discuss pricing and evaluation access. Input downloads and prediction submissions are not available from this preview.

Included datasets

Explore the four RNA-seq datasets included in this paid benchmark suite.

4 datasets

Study 1

T3 + TRH dose response

RNA-seq

Predict the bulk gene-expression response to the T3 + TRH combination across three dose levels, relative to a vehicle control.

Study design: Three combination-dose levels + vehicle
Readout: Bulk RNA-seq

Included in paid suite

Study 2

RSPO pathway perturbations

RNA-seq

RNA-seq arms covering RSPO2, RSPO4, the RSPO2:4 combination, and WAY-316606, alongside a vehicle control.

Study design: Single dose per treatment + vehicle; concentrations TBC
Readout: Bulk RNA-seq

Included in paid suite

Study 3

Farnesol + doxycycline combination

RNA-seq

The RNA-seq component of the farnesol and doxycycline experiment, comparing each single agent and their combination with a vehicle control.

Study design: Single agents + combination + vehicle; concentrations TBC
Readout: Bulk RNA-seq

Included in paid suite

Study 4

Olanzapine + naltrexone combination

RNA-seq

Predict gene-expression responses to olanzapine, naltrexone, and their combination, relative to a vehicle control.

Study design: Single agents + combination + vehicle; concentrations TBC
Readout: Bulk RNA-seq with RIN QC

Included in paid suite

Concentrations marked TBC are not included in the current study metadata.